Home › Giant Cell Arteritis › New York
Giant Cell Arteritis clinical trials in New York
3 studies for Giant Cell Arteritis are looking for participants at sites in New York.
Cities in New York
Abatacept for the Treatment of Giant Cell Arteritis
- Hospital for Special Surgery, New York
RecruitingPhase 3
Ages 50 and older · All sexes · Updated Aug 20, 2026 · NCT04474847Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis
- Northwell Health: Division of Rheumatology and Allergy-Clinical Immunology, Great Neck
- Hospital for Special Surgery, New York: Division of Rheumatology, New York
RecruitingPhase 2
Ages 50 and older · All sexes · Updated Aug 10, 2026 · NCT07108387Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
- NYU Langone Health, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 9, 2026 · NCT07138898From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.